β-catenin-mediated signaling: A molecular target for early chemopreventive intervention

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 555, Issue 1-2 SPEC. ISS., 2004, Pages 97-105

  Clapper, Margie L ^a   Coudry, Jacques ^a   Chang, Wen Chi L ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Catenin; Chemoprevention; TCF; Wnt signaling

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; BETA CATENIN; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CALCIUM; CELECOXIB; CURCUMIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; IMATINIB; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPHENOL; SULINDAC; SULINDAC SULFONE; T CELL FACTOR PROTEIN; TRICHOSTATIN A;

CANCER CELL CULTURE; CARCINOGENESIS; CELL ACTIVITY; CELL COMMUNICATION; CHEMOPROPHYLAXIS; COLON ADENOMA; CYTOLOGY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; BETA CATENIN; CADHERINS; CELL ADHESION; CHEMOPREVENTION; CYTOSKELETAL PROTEINS; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 5144221019     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.05.021     Document Type: Review

References (58)

1. M. van de Wetering, E. Sancho, C. Verweij, W. de Lau, I. Oving, A. Hurlstone, K. van der Horn, E. Batlle, D. Coudreuse, A.P. Haramis, M. Tjon-Pon-Fong, P. Moerer, M. van den Born, G. Soete, S. Pals, M. Eilers, R. Medema, and H. Clevers The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells Cell 111 2002 241 250
2. G.H. Baeg, A. Matsumine, T. Kuroda, R.N. Bhattacharjee, I. Miyashiro, K. Toyoshima, and T. Akiyama The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase EMBO J. 14 1995 5618 5625
3. M. Shtutman, J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway Proc. Natl. Acad. Sci. U.S.A. 96 1999 5522 5527
4. J.M. Mariadason, M. Bordonaro, F. Aslam, L. Shi, M. Kuraguchi, A. Velcich, and L.H. Augenlicht Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation Cancer Res. 61 2001 3465 3471
5. S.M. Powell, N. Zilz, Y. Beazer-Barclay, T.M. Bryan, S.R. Hamilton, S.N. Thibodeau, B. Vogelstein, and K.W. Kinzler APC mutations occur early during colorectal tumorigenesis Nature 359 1992 235 237
6. R. Fodde, R. Smits, and H. Clevers APC, signal transduction and genetic instability in colorectal cancer Nat. Rev. Cancer 1 2001 55 67
7. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
8. P. Polakis Casein kinase 1: a Wnt'er of disconnect Curr. Biol. 12 2002 R499 R501
9. S. Amit, A. Hatzubai, Y. Birman, J.S. Andersen, E. Ben-Shushan, M. Mann, Y. Ben-Neriah, and I. Alkalay Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway Genes Dev. 2002 16
10. Z. Wang, B. Vogelstein, and K.W. Kinzler Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells Cancer Res. 63 2003 5234 5235
11. J. Roose, M. Molenaar, J. Peterson, J. Hurenkamp, H. Brantjes, P. Moerer, M. van de Wetering, O. Destree, and H. Clevers The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors Nature 395 1998 608 612
12. M. Brannon, J.D. Brown, R. Bates, D. Kimelman, and R.T. Moon XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development Development 126 1999 3159 3170
13. J. Behrens, J.P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier Functional interaction of beta-catenin with the transcription factor LEF-1 Nature 382 1996 638 642
14. E. Porfiri, B. Rubinfeld, I. Albert, K. Hovanes, M. Waterman, and P. Polakis Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin Oncogene 15 1997 2833 2839
15. T.-C. He, A.B. Sparks, C. Rago, H. Heiko, L. Zawel, L.T. da Costa, P.J. Morin, B. Vogelstein, and K.W. Kinzler Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
16. T.C. He, T.A. Chan, B. Vogelstein, and K.W. Kinzler PPARd is an APC-regulated target of nonsteroidal anti-inflammatory drugs Cell 99 1999 335 345
17. T. Yamada, T.A.S.Y. Naishiro, R. Hayashi, K. Maruyama, C. Maesawa, A. Ochiai, and S. Hirohashi Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis Cancer Res. 60 2000 4761 4766
18. Y. Araki, S. Okamura, S.P. Hussain, M. Nagashima, P. He, M. Shiseki, K. Miura, and C.C. Harris Regulation of cyclooxygenase-2 expression by the wnt and ras pathways Cancer Res. 63 2003 728 734
19. F.T. Kolligs, M.T. Nieman, I. Winer, G. Hu, D. Van Mater, Y. Feng, I.M. Smith, R. Wu, Y. Zhai, K.R. Cho, and E.R. Fearon ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation Cancer Cell 1 2002 145 155
20. T.A. Chan, Z. Wang, L.H. Dang, B. Vogelstein, and K.W. Kinzler Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation Proc. Natl. Acad. Sci. U.S.A. 99 2002 8265 8270
21. S. Dihlmann, A. Siermann, and M. von Knebel Doeberitz The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling Oncogene 20 2001 645 653
22. N. Nath, K. Kashfi, J. Chen, and B. Rigas Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin-TCF association Proc. Natl. Acad. Sci. U.S.A. 100 2003 12584 12589
23. W.-C.L. Chang, L.C. Everley, H.S. Cooper, A. Barusevicius, and M.L. Clapper Modulation of β-catenin signaling in vitro and in vivo by sulindac sulfone Proc. Am. Assoc. Cancer Res. 2003 44
24. L. Zhou, N. An, R.C. Haydon, Q. Zhou, H. Cheng, Y. Peng, W. Jiang, H.H. Luu, P. Vanichakarn, J.P. Szatkowski, J.Y. Park, B. Breyer, and T.-C. He Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity Cancer Lett. 193 2003 161 170
25. C.J. Torrance, P.E. Jackson, E. Montgomery, K.W. Kinzler, B. Vogelstein, A. Wissner, M. Nunes, P. Frost, and C.M. Discafani Combinatorial chemoprevention of intestinal neoplasia Nat. Med. 6 2000 1024 1028
26. W.A. Brown, S.A. Skinner, D. Vogiagis, and P.E. O'Brien Inhibition of β-catenin translocation in rodent colorectal tumors: a novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancer Dig. Dis. Sci. 46 2001 2314 2321
27. X. Zhang, M.L. Clapper, and W.-C. Chang Tcf-luciferase reporter assay as a screening tool to identify agents that modulate APC/β-catenin signaling Proc. Am. Assoc. Cancer Res. 45 2004 515
28. N.N. Mahmoud, S.K. Boolbol, R.T. Bilinski, C. Martucci, A. Chadburn, and M.M. Bertagnolli Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration Cancer Res. 57 1997 5045 5050
29. N.N. Mahmoud, A.J. Andrew, J. Dannenberg, J. Mestre, R.T. Bilinski, M.R. Churchill, C. Martucci, H. Newmark, and M.M. Bertagnolli Aspirin prevents tumors in a murine model of familial adenomatous polyposis Surgery 124 1998 225 231
30. M.F. McEntee, C.H. Chiu, and J. Whelan Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice Carcinogenesis 20 1999 635 640
31. M.J. Wargovich, A. Jimenez, K. McKee, V.E. Steele, M. Velasco, J. Woods, R. Price, K. Gray, and G.J. Kelloff Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression Carcinogenesis 21 2000 1149 1155
32. D.E. Corpet, and F. Pierre Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system Cancer Epidemiol. Biomarkers Prev. 12 2003 391 400
33. W.-M. Dashwood, G.A. Orner, and R.H. Dashwood Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3- gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrations Biochem. Biophys. Res. Commun. 296 2002 584 588
34. S. Chakrabarty, V. Radjendirane, H. Appelman, and J. Varani Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation Cancer Res. 63 2003 66 71
35. F. Zhang, N.K. Altorki, J.R. Mestre, K. Subbaramaiah, and A.J. Dannenberg Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells Carcinogenesis 20 1999 445 451
36. A. Goel, R. Boland, and D.P. Chauhan Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells Cancer Lett. 172 2001 111 118
37. A.S. Jaiswal, B.P. Marlow, N. Gupta, and S. Narayan β-catenin- mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells Oncogene 21 2002 8414 8427
38. M. Bordonaro, J.M. Mariadason, F. Aslam, B.G. Heerdt, and L.H. Augenlicht Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the β-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin Cell Growth Differ. 10 1999 713 720
39. T.A. Graham, C. Weaver, F. Mao, D. Kimelman, and W. Xu Crystal structure of a beta-catenin/Tcf complex Cell 103 2000 885 896
40. M. Lepourcelet, Y.N. Chen, D.S. France, H. Wang, P. Crews, F. Petersen, C. Bruseo, A.W. Wood, and R.A. Shivdasani Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex Cancer Cell 5 2004 91 102
41. H. Li, L. Liu, M.L. David, C.M. Whitehead, M. Chen, J.R. Fetter, G.J. Sperl, R. Pamukcu, and W.J. Thompson Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation Biochem. Pharmacol. 64 2002 1325 1336
42. P.L. Rice, J. Kelloff, H. Sullivan, L.J. Driggers, K.S. Beard, S. Kuwada, G. Piazza, and D.J. Ahnen Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells Mol. Cancer Ther. 2 2003 885 892
43. M.K. Kwak, N. Wakabayashi, J.L. Greenlaw, M. Yamamoto, and T.W. Kensler Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway Mol. Cell Biol. 23 2003 8786 8794
44. B.M. Gumbiner Cell adhesion: the molecular basis of tissue architecture and morphogenesis Cell 84 1996 345 357
45. W.J. Nelson, and R. Nusse Convergence of Wnt, β-catenin, and cadherin pathways Science 303 2004 1483 1487
46. K.M. Hajra, and E.R. Fearon Cadherin and catenin alterations in human cancer Genes Chromosomes Cancer 34 2002 255 268
47. K.F. Kelly, C.M. Spring, A.A. Otchere, and J.M. Daniel NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression J. Cell Sci. 117 2004 2675 2686
48. J. van Hengel, P. Vanhoenacker, K. Staes, and F. van Roy Nuclear localization of the p120(ctn) Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression Proc. Natl. Acad. Sci. U.S.A. 1999 96
49. A. Prokhortchouk, B. Hendrich, H. Jorgensen, A. Ruzov, M. Wilm, G. Georgiev, A. Bird, and E. Prokhortchouk The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor Genes Dev. 15 2001 1613 1618
50. H.G. Yoon, D.W. Chan, A.B. Reynolds, J. Qin, and J. Wong N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso Mol. Cell 12 2003 723 734
51. J.M. Daniel, C.M. Spring, H.C. Crawford, A.B. Reynolds, and A. Baig The p120ctn-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides Nucl. Acids Res. 30 2002 2911 2919
52. S.W. Kim, X. Fang, H. Ji, A.F. Paulson, J.M. Daniel, M. Ciesiolka, F. van Roy, and P.D. McCrea Isolation and characterization of XKaiso, a transcriptional repressor that associates with the catenin Xp120ctn in Xenopus laevis J. Biol. Chem. 277 2002 8202 8208
53. Q. Meng, M. Qi, D.Z. Chen, R. Yuan, I.D. Goldberg, E.M. Rosen, K. Auborn, and S. Fan Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes J. Mol. Med. 78 2000 155 165
54. M.E. Brack, T. Boterberg, H.T. Depypere, C. Stove, G. Leclercq, and M.M. Mareel The citrus methoxyflavone tangeretin affects human cell-cell interactions Adv. Exp. Med. Biol. 505 2002 135 139
55. F. Zhang, R.L. White, and K.L. Neufeld Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein Proc. Natl. Acad. Sci. U.S.A. 97 2000 12577 12582
56. K.L. Neufeld, D.A. Nix, H. Bogerd, Y. Kang, M.C. Beckerle, B.R. Cullen, and R.L. White Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm Proc. Natl. Acad. Sci. U.S.A. 97 2000 12085 12090
57. B.R. Henderson Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover Nat. Cell Biol. 2 2000 653 660
58. H.C. Crawford, B.M. Fingleton, L.A. Rudolph-Owen, K.J. Goss, B. Rubinfeld, P. Polakis, and L.M. Matrisian The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors Oncogene 18 1999 2883 2891